Spyre Therapeutics executives sell millions in stock

Executives at Spyre Therapeutics have conducted significant stock sales totaling several million dollars. The transactions involved the Chief Financial Officer, Chief Legal Officer, and CEO.

CFO Scott Burrows sold shares totaling approximately $1.57 million on September 30, while also executing other trades totaling roughly $2.26 million. Chief Legal Officer Heidy King-Jones sold 28,933 shares for approximately $2.63 million on October 1. CEO Cameron Turtle sold 14,000 shares valued at about $1.38 million.

These sales were executed under pre-arranged Rule 10b5-1 trading plans, which are established in advance to avoid conflicts regarding non-public information. The sales occurred following a period of significant stock price appreciation for the company.